Author's reply to: The real-world outcome of metastatic melanoma: Unknown primary vs. known cutaneous

Int J Cancer. 2019 Dec 1;145(11):3175-3176. doi: 10.1002/ijc.32630. Epub 2019 Sep 3.

Authors

Danielle Verver¹, Astrid A M van der Veldt², Alexander C J van Akkooi³, Kees Verhoef¹, Dirk J Grünhagen¹, Marieke W J Louwman⁴

Affiliations

¹ Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
² Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
³ Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
⁴ Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.

PMID: 31423580
DOI: 10.1002/ijc.32630

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Cutaneous
Humans
Immunotherapy
Melanoma*
Neoplasms, Unknown Primary*
Skin Neoplasms*